Surmodics Income After Taxes 2010-2024 | SRDX
Surmodics income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Surmodics Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $-12 |
| 2023 | $-2 |
| 2022 | $-27 |
| 2021 | $4 |
| 2020 | $1 |
| 2019 | $8 |
| 2018 | $-4 |
| 2017 | $4 |
| 2016 | $10 |
| 2015 | $12 |
| 2014 | $12 |
| 2013 | $15 |
| 2012 | $10 |
| 2011 | $11 |
| 2010 | $0 |
| 2009 | $38 |
| Surmodics Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-4 |
| 2024-09-30 | $-3 |
| 2024-06-30 | $-8 |
| 2024-03-31 | $0 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $7 |
| 2023-06-30 | $7 |
| 2023-03-31 | $-8 |
| 2022-12-31 | $-8 |
| 2022-09-30 | $-15 |
| 2022-06-30 | $-6 |
| 2022-03-31 | $-4 |
| 2021-12-31 | $-3 |
| 2021-09-30 | $0 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $8 |
| 2020-12-31 | $0 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $2 |
| 2020-03-31 | $1 |
| 2019-12-31 | $0 |
| 2019-09-30 | $4 |
| 2019-06-30 | $1 |
| 2019-03-31 | $1 |
| 2018-12-31 | $1 |
| 2018-09-30 | $-2 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $2 |
| 2017-12-31 | $-2 |
| 2017-09-30 | $0 |
| 2017-06-30 | $1 |
| 2017-03-31 | $1 |
| 2016-12-31 | $2 |
| 2016-09-30 | $3 |
| 2016-06-30 | $4 |
| 2016-03-31 | $1 |
| 2015-12-31 | $3 |
| 2015-09-30 | $1 |
| 2015-06-30 | $4 |
| 2015-03-31 | $3 |
| 2014-12-31 | $4 |
| 2014-09-30 | $2 |
| 2014-06-30 | $4 |
| 2014-03-31 | $2 |
| 2013-12-31 | $4 |
| 2013-09-30 | $4 |
| 2013-06-30 | $3 |
| 2013-03-31 | $3 |
| 2012-12-31 | $4 |
| 2012-09-30 | $3 |
| 2012-06-30 | $3 |
| 2012-03-31 | $2 |
| 2011-12-31 | $2 |
| 2011-09-30 | $2 |
| 2011-06-30 | $3 |
| 2011-03-31 | $3 |
| 2010-12-31 | $3 |
| 2010-09-30 | $-22 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $0 |
| 2009-12-31 | $2 |
| 2009-09-30 | $3 |
| 2009-06-30 | $4 |
| 2009-03-31 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.383B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.816B | 27.87 |
| Boston Scientific (BSX) | United States | $152.176B | 38.10 |
| Stryker (SYK) | United States | $145.393B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $127.544B | 0.00 |
| Medtronic (MDT) | Ireland | $107.067B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.941B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.439B | 27.54 |
| ResMed (RMD) | United States | $35.929B | 26.99 |
| GE HealthCare Technologies (GEHC) | United States | $31.992B | 15.19 |
| Agilent Technologies (A) | United States | $30.486B | 20.14 |
| Terumo (TRUMY) | Japan | $28.205B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.066B | 16.58 |
| Insulet (PODD) | United States | $21.859B | 85.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.837B | 12.10 |
| Baxter (BAX) | United States | $15.857B | 11.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.412B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.686B | 22.60 |
| Lantheus Holdings (LNTH) | United States | $5.598B | 14.27 |
| Prestige Consumer Healthcare (PBH) | United States | $4.325B | 19.27 |
| Perrigo (PRGO) | Ireland | $3.713B | 9.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.426B | 14.92 |
| ICU Medical (ICUI) | United States | $3.404B | 25.10 |
| Envista Holdings (NVST) | United States | $2.981B | 24.77 |
| QuidelOrtho (QDEL) | United States | $2.451B | 16.90 |
| GN Store Nord (GNNDY) | Denmark | $2.075B | 17.19 |
| LeMaitre Vascular (LMAT) | United States | $1.813B | 40.54 |
| AtriCure (ATRC) | United States | $1.534B | 0.00 |
| Neogen (NEOG) | United States | $1.296B | 16.58 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.164B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.156B | 11.75 |
| BioLife Solutions (BLFS) | United States | $1.106B | 0.00 |
| InMode (INMD) | Israel | $1.005B | 9.20 |
| Phibro Animal Health (PAHC) | United States | $0.910B | 11.64 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.575B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Owens & Minor (OMI) | United States | $0.542B | 4.49 |
| Valneva SE (VALN) | France | $0.541B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.431B | 0.00 |
| Omeros (OMER) | United States | $0.360B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.290B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.283B | 10.42 |
| Aurora Cannabis (ACB) | Canada | $0.273B | 48.50 |
| Sanuwave Health (SNWV) | United States | $0.257B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.250B | 21.07 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.09 |
| Canopy Growth (CGC) | Canada | $0.241B | 0.00 |
| Biote (BTMD) | United States | $0.219B | 6.15 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.18 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.162B | 0.00 |
| Organigram Global (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.16 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.103B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.77 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| United-Guardian (UG) | United States | $0.037B | 12.79 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |